IL33 and neoplasm: Moreover, another study by Babadi AS et al. (72) showed that IL-33-ST2 signaling resulted in programmed death of low-metastatic Lewis lung cancer cells, whereas high-metastatic cells were not substantially affected, which eventually facilitated tumor growth.